Daniell Richard
Insider CIK 1726096 · TEVA Exec. VP, European Commercial
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-05-05 | 2026-05-07 | 30,000 | $35.40 | $1.06M | 55,755 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-05 | 2026-03-09 | 17,295 | — | $0 | 51,887 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-05 | 2026-03-09 | 17,295 | — | $0 | 103,050 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-03-05 | 2026-03-09 | 17,295 | $31.67 | $547.7K | 85,755 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-04 | 2026-03-06 | 20,461 | — | $0 | 40,923 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2026-03-04 | 2026-03-06 | 33,424 | — | $0 | 33,424 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-04 | 2026-03-06 | 33,512 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-03-04 | 2026-03-06 | 20,461 | $32.46 | $664.2K | 123,127 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-03-04 | 2026-03-06 | 37,372 | $32.95 | $1.23M | 85,755 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-04 | 2026-03-06 | 33,512 | — | $0 | 156,639 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-03-04 | 2026-03-06 | 33,512 | $32.46 | $1.09M | 123,127 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-04 | 2026-03-06 | 20,461 | — | $0 | 143,588 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-03 | 2026-03-05 | 141,478 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-03 | 2026-03-05 | 62,250 | — | $0 | 62,253 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-03-03 | 2026-03-05 | 62,250 | $32.36 | $2.01M | 48,384 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-03 | 2026-03-05 | 141,478 | — | $0 | 189,862 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-03-03 | 2026-03-05 | 66,735 | $32.36 | $2.16M | 123,127 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-03 | 2026-03-05 | 62,250 | — | $0 | 110,634 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2026-01-27 | 2026-01-29 | 141,478 | — | $0 | 141,478 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-12-09 | 2025-12-11 | 15,011 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-12-09 | 2025-12-11 | 100,457 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-12-09 | 2025-12-11 | 115,468 | $28.68 | $3.31M | 48,384 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-12-09 | 2025-12-11 | 15,011 | $16.99 | $255.0K | 163,852 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-12-09 | 2025-12-11 | 100,457 | $18.61 | $1.87M | 148,841 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-03-05 | 2025-03-07 | 22,576 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2025-03-05 | 2025-03-07 | 69,182 | — | $0 | 69,182 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-03-05 | 2025-03-06 | 30,015 | $15.91 | $477.5K | 96,769 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-03-05 | 2025-03-06 | 11,641 | $15.91 | $185.2K | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-03-05 | 2025-03-06 | 7,108 | $15.91 | $113.1K | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-03-05 | 2025-03-07 | 22,576 | — | $0 | 119,345 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-03-05 | 2025-03-07 | 22,576 | $15.91 | $359.2K | 96,769 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-03-05 | 2025-03-07 | 48,385 | $15.90 | $769.3K | 48,384 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-03-04 | 2025-03-06 | 20,461 | — | $0 | 61,384 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-03-04 | 2025-03-06 | 183,169 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-03-04 | 2025-03-06 | 33,512 | — | $0 | 33,512 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-03-04 | 2025-03-05 | 12,936 | $15.56 | $201.3K | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-03-04 | 2025-03-06 | 33,512 | — | $0 | 33,512 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-03-04 | 2025-03-06 | 21,870 | $15.73 | $344.0K | 11,641 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-03-04 | 2025-03-06 | 20,461 | — | $0 | 20,461 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-03-04 | 2025-03-06 | 13,353 | $15.73 | $210.0K | 7,108 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-03-04 | 2025-03-06 | 56,385 | $15.73 | $886.9K | 126,784 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-03-04 | 2025-03-06 | 183,169 | — | $0 | 183,169 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-03-03 | 2025-03-05 | 62,250 | — | $0 | 124,503 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-03-03 | 2025-03-05 | 62,250 | — | $0 | 62,250 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-03-03 | 2025-03-05 | 49,314 | $16.19 | $798.4K | 12,936 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2025-01-28 | 2025-01-30 | 183,169 | — | $0 | 183,169 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2024-08-12 | 2024-08-13 | 98,943 | $17.30 | $1.71M | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-03-05 | 2024-03-07 | 55,226 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-03-05 | 2024-03-07 | 22,576 | — | $0 | 22,576 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-03-05 | 2024-03-07 | 22,576 | — | $0 | 92,346 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-03-05 | 2024-03-07 | 55,226 | — | $0 | 124,996 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2024-03-05 | 2024-03-07 | 26,053 | $13.52 | $352.2K | 98,943 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2024-03-05 | 2024-03-07 | 22,576 | $13.52 | $305.2K | 69,770 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-03-04 | 2024-03-05 | 33,512 | — | $0 | 67,024 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2024-03-04 | 2024-03-05 | 81,845 | — | $0 | 81,845 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2024-03-04 | 2024-03-05 | 62,250 | $13.34 | $830.4K | 69,770 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2024-03-04 | 2024-03-05 | 33,512 | $13.34 | $447.1K | 69,770 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-03-04 | 2024-03-05 | 33,512 | — | $0 | 103,282 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-03-03 | 2024-03-05 | 62,250 | — | $0 | 186,753 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-03-03 | 2024-03-05 | 62,250 | — | $0 | 132,020 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-02-28 | 2024-03-01 | 20,599 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2024-02-28 | 2024-03-01 | 20,599 | $13.12 | $270.3K | 69,770 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-02-28 | 2024-03-01 | 20,599 | — | $0 | 90,369 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2024-01-30 | 2024-02-01 | 55,226 | — | $0 | 55,226 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2023-03-07 | 2023-03-08 | 54,007 | $9.43 | $509.3K | 69,770 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2023-03-06 | 2023-03-08 | 18,002 | $9.93 | $178.8K | 123,777 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-03-05 | 2023-03-07 | 22,576 | — | $0 | 45,152 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-03-05 | 2023-03-07 | 22,576 | — | $0 | 141,779 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-03-04 | 2023-03-07 | 33,512 | — | $0 | 100,536 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-03-04 | 2023-03-07 | 15,921 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-03-04 | 2023-03-07 | 33,512 | — | $0 | 119,203 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-03-04 | 2023-03-07 | 15,921 | — | $0 | 85,691 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2023-03-03 | 2023-03-07 | 249,003 | — | $0 | 249,003 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-02-28 | 2023-03-02 | 20,598 | — | $0 | 20,599 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-02-28 | 2023-03-02 | 50,242 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-02-28 | 2023-03-02 | 20,598 | — | $0 | 63,780 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-02-28 | 2023-03-02 | 50,242 | — | $0 | 93,424 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2023-02-28 | 2023-03-02 | 20,598 | $9.89 | $203.7K | 43,182 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2023-02-28 | 2023-03-02 | 23,654 | $9.89 | $233.9K | 69,770 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2023-02-07 | 2023-02-09 | 50,242 | — | $0 | 50,242 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2022-03-07 | 2022-03-08 | 22,576 | $7.37 | $166.4K | 43,182 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-03-05 | 2022-03-08 | 22,576 | — | $0 | 67,728 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-03-05 | 2022-03-08 | 22,576 | — | $0 | 65,758 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-03-04 | 2022-03-08 | 43,358 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2022-03-04 | 2022-03-08 | 134,048 | — | $0 | 134,048 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-03-04 | 2022-03-08 | 15,920 | — | $0 | 15,921 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-03-04 | 2022-03-08 | 15,920 | — | $0 | 36,200 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2022-03-04 | 2022-03-08 | 15,920 | $7.48 | $119.1K | 20,280 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-03-04 | 2022-03-08 | 43,358 | — | $0 | 63,638 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2022-03-04 | 2022-03-08 | 20,456 | $7.48 | $153.0K | 43,182 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-02-28 | 2022-03-02 | 20,598 | — | $0 | 41,197 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-02-28 | 2022-03-02 | 20,598 | — | $0 | 40,878 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2022-02-28 | 2022-03-02 | 20,598 | $8.14 | $167.7K | 20,280 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-02-09 | 2022-02-10 | 13,135 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2022-02-09 | 2022-02-10 | 13,135 | $9.06 | $119.0K | 20,280 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-02-09 | 2022-02-10 | 13,135 | — | $0 | 33,415 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2022-02-08 | 2022-02-10 | 43,358 | — | $0 | 43,358 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2021-03-05 | 2021-03-08 | 90,304 | — | $0 | 90,304 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-03-04 | 2021-03-08 | 15,920 | — | $0 | 31,841 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-03-04 | 2021-03-08 | 7,513 | $10.58 | $79.5K | 20,280 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-03-04 | 2021-03-08 | 15,920 | — | $0 | 27,793 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-03-03 | 2021-03-04 | 2,101 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-03-03 | 2021-03-04 | 993 | $10.88 | $10.8K | 11,873 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-03-03 | 2021-03-04 | 2,101 | — | $0 | 12,866 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-03-01 | 2021-03-02 | 20,598 | $10.85 | $223.5K | 10,765 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-02-28 | 2021-03-02 | 20,598 | — | $0 | 61,795 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-02-28 | 2021-03-02 | 20,598 | — | $0 | 31,363 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-02-09 | 2021-02-11 | 13,135 | — | $0 | 13,135 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-02-09 | 2021-02-11 | 13,135 | — | $0 | 23,900 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award | 2021-02-09 | 2021-02-11 | 55,287 | — | $0 | 79,187 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-02-09 | 2021-02-11 | 13,135 | $12.72 | $167.1K | 66,052 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-02-09 | 2021-02-11 | 55,287 | $12.72 | $703.3K | 10,765 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-09-09 | 2020-09-10 | 698 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-09-09 | 2020-09-10 | 698 | — | $0 | 11,098 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2020-09-09 | 2020-09-10 | 333 | $8.98 | $3.0K | 10,765 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-03-17 | 2020-03-19 | 1,297 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-03-17 | 2020-03-19 | 1,297 | — | $0 | 11,016 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2020-03-17 | 2020-03-19 | 616 | $7.17 | $4.4K | 10,400 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-03-03 | 2020-03-05 | 2,098 | — | $0 | 2,101 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2020-03-03 | 2020-03-05 | 991 | $11.77 | $11.7K | 9,719 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-03-03 | 2020-03-05 | 2,098 | — | $0 | 10,710 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2020-02-28 | 2020-03-03 | 82,393 | — | $0 | 82,393 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2020-02-10 | 2020-02-11 | 6,199 | $12.24 | $75.9K | 8,612 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-02-09 | 2020-02-11 | 13,135 | — | $0 | 26,270 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-02-09 | 2020-02-11 | 13,135 | — | $0 | 14,811 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-09-18 | 2019-09-20 | 2,489 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2019-09-18 | 2019-09-20 | 1,176 | $7.82 | $9.2K | 1,676 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-09-18 | 2019-09-20 | 2,489 | — | $0 | 2,852 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-09-09 | 2019-09-11 | 696 | — | $0 | 698 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-09-09 | 2019-09-11 | 696 | — | $0 | 696 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2019-09-09 | 2019-09-11 | 333 | $7.16 | $2.4K | 363 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2019-03-18 | 2019-03-19 | 1,297 | $16.64 | $21.6K | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-03-17 | 2019-03-19 | 1,297 | — | $0 | 1,297 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-03-17 | 2019-03-19 | 1,297 | — | $0 | 1,297 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-03-12 | 2019-03-14 | 715 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-03-12 | 2019-03-14 | 715 | — | $0 | 715 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2019-03-12 | 2019-03-14 | 715 | $15.69 | $11.2K | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2019-03-04 | 2019-03-06 | 47,761 | — | $0 | 47,761 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2019-03-04 | 2019-03-05 | 2,098 | $16.88 | $35.4K | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-03-03 | 2019-03-05 | 2,098 | — | $0 | 4,199 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-03-03 | 2019-03-05 | 2,098 | — | $0 | 2,098 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-09-18 | 2018-09-20 | 2,488 | — | $0 | 2,489 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-09-18 | 2018-09-20 | 2,488 | — | $0 | 2,488 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2018-09-18 | 2018-09-20 | 2,488 | $23.69 | $58.9K | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2018-09-10 | 2018-09-11 | 696 | $21.25 | $14.8K | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-09-09 | 2018-09-11 | 696 | — | $0 | 1,394 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-09-09 | 2018-09-11 | 696 | — | $0 | 696 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2018-03-19 | 2018-03-20 | 1,297 | $17.89 | $23.2K | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-03-17 | 2018-03-20 | 1,297 | — | $0 | 2,594 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-03-17 | 2018-03-20 | 1,297 | — | $0 | 1,297 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-03-12 | 2018-03-14 | 714 | — | $0 | 715 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-03-12 | 2018-03-14 | 714 | — | $0 | 714 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2018-03-12 | 2018-03-14 | 714 | $19.50 | $13.9K | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2018-03-05 | 2018-03-06 | 1,108 | $19.28 | $21.4K | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | F Tax w/h | 2018-03-05 | 2018-03-06 | 990 | $19.28 | $19.1K | 1,108 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-03-03 | 2018-03-06 | 2,098 | — | $0 | 6,297 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-03-03 | 2018-03-06 | 2,098 | — | $0 | 2,098 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2018-02-09 | 2018-02-12 | 100,457 | — | $0 | 100,457 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2018-02-09 | 2018-02-12 | 39,405 | — | $0 | 39,405 | SEC↗ |